Ayurvedic management of diabetes

An Open Label Double Arm Clinical Trial To Determine The Efficacy Of D 4 Combination Along With Ongoing Conventional Medicine In Managing Diabetes Mellitus (Type 2 )

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019370

Enrollment

Registered

2019-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Combination D-4: Jamun beej churna, Gudmar patra churna 5gms each twice a day before breakfast and dinner

and Giloy churna and Nagarmotha churna 5gm each after breakfast and dinner for three months Control Intervention1: Conventional with Placebo Capsules: One placebo capsule of 500 mg twice a day after f

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Prabhuta Mutrata, Avila Mutrata, with some or on purvaroopa -Jtilibhavkesesu, Madhuryamaasya, Karpadyosuptataadhaho, Mukhatalukanthasosham, Pipasadhikya, Alasya Nidra, Tandra. Criteria for diagnosis of DM by American Diabetes Association Newly /Early diagnosed(0-3 year) cases to be included as per following criteria: Patients who are taking conventional medicine treatment for diabetes. Patient accidently diagnosed in routine check-up or when appeared with other complaints in the hospital.

Exclusion criteria

Exclusion criteria: Emergency cases in DM. Patients having insulin dependent DM (IDDM) and receiving insulin (type 1) Excessive blood glucose: FBS > 300 mg/dl and PPBS > 450 mg/dl. Chronic complications like microvascular and macrovascular. Patients reporting to be hypersensitive to any of the proposed trial drug.

Design outcomes

Primary

Measure	Time frame
1.Glycosylated haemoglobin (in %) â?? HbA1C 2.Blood sugar fasting and post parandial (in mg/dl) 3.Period of tapering process of the conventional medicine. Timepoint: 3 MONTHS	—

Secondary

Measure	Time frame
Urine routine and microscopic examination â??albumin,sugar,casts/crystals,epithelialcells,pus cells. Haemogram with ESR, ketone bodies, Lipid Profile, Liver Function Test And Kidney Function Test Quality of life in DM assessment scale Daytime sleepiness scale Fatigue assessment scale and fatigue severity scale. Timepoint: 3 MONTHS	—

Countries

India

Contacts

Public ContactDr Shyam

All India Institute of Ayurveda

mahtorajaram@yahoo.com8877033663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026